Health Care & Life Sciences » Biotechnology | Chongqing Zhifei Biological Products Co. Ltd.

Chongqing Zhifei Biological Products Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
772
794
708
440
1,330
5,200
Cost of Goods Sold (COGS) incl. D&A
321
323
157
65
324
2,419
Gross Income
451
471
551
376
1,007
2,781
SG&A Expense
301
313
349
334
482
1,048
EBIT
122
151
201
18
493
1,719
Unusual Expense
1
-
2
1
-
4
Non Operating Income/Expense
1
1
1
1
9
10
Interest Expense
-
-
-
-
8
36
Pretax Income
153
176
231
36
505
1,692
Income Tax
22
27
33
3
72
241
Equity in Affiliates
-
-
1
-
-
-
Consolidated Net Income
130
148
197
33
432
1,451
Net Income
130
148
197
33
432
1,451
Net Income After Extraordinaries
130
148
197
33
432
1,451
Net Income Available to Common
130
148
197
33
432
1,451
EPS (Basic)
0.08
0.10
0.13
0.02
0.27
0.91
Basic Shares Outstanding
1,600
1,600
1,600
1,600
1,600
1,600
EPS (Diluted)
0.08
0.09
0.12
0.02
0.27
0.91
Diluted Shares Outstanding
1,600
1,600
1,600
1,600
1,600
1,600
EBITDA
150
185
238
68
555
1,811
Other Operating Expense
28
7
2
23
31
13
Non-Operating Interest Income
28
25
28
18
22
16

About Chongqing Zhifei Biological Products Co.

View Profile
Address
25th floor, 7 Jinyuan Road
Chongqing Chongqing 400020
China
Employees -
Website http://www.zhifeishengwu.com
Updated 07/08/2019
Chongqing Zhifei Biological Products Co., Ltd. engages in the wholesale of biological products and vaccines. Its main products are meningococcal group A&C conjugate vaccine, meningococcal polysaccharide vaccine, mycobacterium vaccae, Haemophilus Influenzae type b conjugate vaccine, and freeze-dried live attenuated hepatitis A vaccine. Its other activities are biotechnology research, development, and consulting; import and export, and storage services.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.